brecadd regimen is superior in treating advanced hl: results from the hd21 trial
Published 2 weeks ago • 62 plays • Length 6:37Download video MP4
Download video MP3
Similar videos
-
2:29
findings from the hd21 trial: safety profile of the brecadd regimen in hl
-
2:27
insights into the brecadd regimen in hl & results from the ghsg hd21 study
-
1:47
updates from the hd21 study: escalated beacopp vs brecadd for the treatment of hl
-
5:02
hd21: treatment-related morbidity in patients with hodgkin lymphoma treated with brecadd vs ebeacopp
-
1:37
brecadd versus beacopp in advanced hl: a german hodgkin study group investigation
-
4:59
hodgkins lymphoma recovery - 5 months later
-
22:58
gość radia lublin: prof. krzysztof giannopoulos
-
33:50
is own brand labelling (obl) still possible with mdr or ivdr?
-
1:30
advances in the management of r/r hodgkin lymphoma
-
1:26
promising results from the swog s1826 trial: nivo-avd versus bv-avd in patients with chl
-
3:42
early pet-adapted treatment for hodgkin lymphoma: 10-year follow-up analysis
-
6:30
ghsd hd18 study: reducing chemotherapy toxicity in advanced stage hodgkin lymphoma
-
6:30
phase iii asap trial results: role of remission induction chemotherapy before allohct in r/r aml
-
2:28
treatment approaches for patients with r/r dlbcl: uk perspective
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
3:38
advances in hematology: jacob rowe, md
-
2:39
brac1 and brac2 mutations
-
16:39
adrenal vein sampling
-
2:15
promising advances in the field of ptcl: druggable mutations, brentuximab vedotin & l-asparaginase
-
7:30
generics and biosimilars
-
1:33
blood advances